CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches

Maria A Argiriadi1, Lorenzo Benatuil2, Ievgeniia Dubrovska3

  • 1AbbVie Bioresearch Center, 381 Plantation Street, Worcester, MA, 01605, USA. maria.argiriadi@abbvie.com.

Insights

Structural analysis of CD40 antibodies reveals how antagonists like ABBV-323 stabilize receptor dimers, offering a mechanism for treating inflammatory diseases and cancer.

Area of Science:

  • Immunology
  • Structural Biology
  • Drug Discovery

Background:

  • CD40 is a transmembrane protein on immune cells, crucial for immune responses.
  • Its role in chronic inflammation makes CD40 a therapeutic target for autoimmune diseases and cancer.

Purpose of the Study:

  • To elucidate the mechanism of action for anti-CD40 monoclonal antibodies (mAbs).
  • To understand the structural basis for CD40 antagonism and agonism.

Main Methods:

  • X-ray crystallography was used to determine the structures of ABBV-323 Fab alone and complexed with CD40.
  • The structure of a related agonist antibody, FAB516, complexed with CD40 was also determined.

Main Results:

  • Identified the specific CD40 epitope recognized by the antagonist ABBV-323.
  • Observed conformational changes in ABBV-323's complementarity-determining regions (CDRs) upon binding to CD40.
  • Revealed a structural hypothesis for the agonist/antagonist switch involving the light chain CDR1 (LCDR1).

Conclusions:

  • ABBV-323 antagonizes CD40 by stabilizing its functional antiparallel dimer through novel LCDR1 interactions (R32).
  • The agonist FAB516 shows monomeric recognition and lacks these LCDR1 contacts due to an L32 mutation.
  • These findings provide a structural foundation for the antagonist activity of ABBV-323.
Abstract

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
8.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Assembly of Complex Microtubule Structures01:32

Assembly of Complex Microtubule Structures

Complex microtubule structures are present in resting cells and in dividing cells. In resting cells, they are responsible for maintaining the cellular architecture, tracks for intracellular transport, positioning of organelles, assembly of cilia and flagella. They mediate the bipolar spindle assembly for chromosomal segregation and positioning of the cell division plate in dividing cells. The formation of microtubule complex structures depends on the cell type, cell stage, and cell function.
2.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.0K